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Cholangiocyteosis (CF) indicate that sulfotransferase (SULT) 1E1 is signiﬁcantly induced in livers
of many mice lacking cystic ﬁbrosis transmembrane receptor (CFTR) activity. Increased SULT1E1 activity
results in the alteration of estrogen-regulated protein expression in the livers of these mice. In this study,
human MMNK-1 cholangiocytes with repressed CFTR function were used to induce SULT1E1 expression in
human HepG2 hepatocytes to investigate whether SULT1E1 can be increased in human CF liver. CFTR
expression was inhibited in MMNK-1 cholangiocytes using CFTR-siRNA, then the MMNK-1 and HepG2 cells
were co-cultured in a membrane-separated Transwell system. Expression of SULT1E1 and selected estrogen-
regulated proteins were then assayed in the HepG2 cells. Results demonstrate that inhibition of CFTR
expression in MMNK-1 cells results in the induction of SULT1E1 message and activity in HepG2 cells in the
Transwell system. The expression of estrogen-regulated proteins including insulin-like growth factor (IGF)-1,
glutathione-S-transferase (GST) P1 and carbonic anhydrase (CA) II expression are repressed in the HepG2
cells cultured with the CFTR-siRNA-MMNK-1 cells apparently in response to the increased sulfation of β-
estradiol. Thus, we have shown that co-culture of HepG2 hepatocytes with MMNK-1 cholangiocytes with
siRNA repressed CFTR expression results in the selective induction of SULT1E1 in the HepG2 cells. Loss of
CFTR function in cholangiocytes may have a paracrine regulatory effect on hepatocytes via the induction of
SULT1E1 and the increased sulfation of β-estradiol. Experiments are presently underway in our laboratory to
elucidate the identity of these paracrine regulatory factors.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Cystic ﬁbrosis (CF) is a chronic, progressive, genetic disease that
affects approximately 1 of every 2500 Caucasian newborns [1] and is
caused by mutations in the cystic ﬁbrosis transmembrane receptor
(CFTR) gene. Although lung disease is the primary cause of morbidity
and mortality, non-pulmonary disorders including pancreatic, liver
and intestinal diseases are also becoming more prevalent as the
lifespan of CF patients increases. With improved pulmonary therapy
CF patient survival often extends into adulthood and liver disease (LD)
has become the second leading cause of death in CF [2,3]. The
initiating event in CFLD development is unknown; however, CFLD
appears as a progressive ﬁbrogenic process that leads to cirrhosis in
some patients [4]. Approximately 15–20% of CF patients are diagnosed
with CFLD in childhood and the progression of the disease occurs
within this group [1,3]. Genetic and environmental factorsmaymodify
this process and be factors in explaining the heterogeneity in the liver
response to abnormal CFTR function [5]. To date, a cohesive
mechanism explaining the pathogenesis of CFLD is lacking.1 205 934 9888.
ny).
l rights reserved.In mouse models of CF generated by expression of improperly
processed CFTR (Δ508) or lacking CFTR expression (knockout, KO),
there is a selective induction of sulfotransferase 1E1 (SULT1E1) in liver
hepatocytes [6]. SULT1E1 catalyzes the conjugation of estrogens with
a charged sulfonate group that represents an important metabolic
reaction in the inactivation of estrogens at physiological concentra-
tions [7–9]. Sulfated estrogens cannot bind to and activate the
estrogen receptors and thus lose their estrogenic activities. SULT1E1
is a cytosolic enzyme in mammalian hepatocytes whose expression is
readily detectable inmouse hepatocytes and human hepatoma HepG2
cells and liver specimens [7,10,11].
Whereas SULT1E1 is expressed in hepatocytes in the liver, CFTR is
selectively expressed in cholangiocytes in the apical membrane [12].
The mechanism by which the absence of CFTR in the apical plasma
membrane of cholangiocytes leads to the clinical manifestations of
CFLD is unknown, and functional studies with primary CF cholangio-
cytes are limited [4]. The secretion of bile by the liver depends upon
functional interactions between hepatocytes and cholangiocytes, and
a deﬁcit in bile ﬂow is one problem encountered in CF liver [13]. The
induction of SULT1E1 in hepatocytes of CFTR(−/−) mice indicates an
apparent separate interaction between the loss of CFTR function in
cholangiocytes and hepatocytes. Cholangiocytes in CFTR(−/−) mice are
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unknown mechanism. The induction of SULT1E1 activity in the livers
of CFTR(−/−) mice also provides a mechanism for the disruption of the
hormonal regulation of liver function via a signiﬁcant increase in E2
inactivation and alteration of the expression of E2-regulated genes [7].
The present study utilizes two human cell lines to investigate the
interaction between hepatocytes and cholangiocytes in human CF. It is
not known whether the loss of CFTR function in human cholangio-
cytes is associated with the induction of SULT1E1 in human liver. This
analysis is hindered by the very limited availability of human CF liver
specimens. Therefore, a co-culture system utilizing human cholangio-
cytes and hepatocytes was developed to investigate the paracrine
interactions between these cells in the regulation of SULT1E1
expression. MMNK-1 cells are an immortalized human cholangiocyte
cell line that expresses CFTR [7,14]. HepG2 hepatocytes express
SULT1E1 and the stable over-expression of SULT1E1 in these cells
disrupts E2-regulated processes including growth hormone stimu-
lated STAT5b phosphorylation and IGF-1 expression (unpublished
observation). CFTR expression in MMNK-1 cells was inhibited using
siRNA and the effect of the loss of CFTR function on expression of
SULT1E1 in HepG2 cells investigated in a membrane-separated co-
culture Transwell system.
2. Materials and methods
HepG2 cells were purchased from the American Type Culture
Collection (Rockville, MD). MMNK-1 cells were from Dr. Melissa
Runge-Morris (Wayne State University, Detroit, MI). [3H]-E2 (56 Ci/
mmol) was purchased from DuPont–NEN (Boston, MA). 3′-Phosphoa-
denosine 5′-phosphosulphate (PAPS) was from Dr. Sanford Singer
(University of Dayton, Dayton, OH). RNA STAT-60 was purchased from
Tel-Test (Friendswood, TX). Supersensitive Link-Label IHC Detection
Systemwas from BioGenex (San Ramon, CA). Mouse monoclonal anti-
human CFTR antibody (MM13-4) was fromGeneTex (San Antonio, TX).
The siRNA expression vector pRNA-U6.1/Zeo was obtained from
GenScript Corp. (Piscataway, NJ). TaqMan® Universal PCR Master
Mix and TaqMan® Gene Expression Assays for human SULT1E1
(Hs00192690), SULT1A1 (Hs00742033), IGF-1 (00153126) and eukar-
yotic 18S ribosomal RNA (4319413E) were obtained from Applied
Biosystems (Foster City, CA). Cell culture Transwell inserts were from
Corning Incorporated (Acton, MA). Biotin-SP-conjugated afﬁniPure
Goat anti-Mouse IgG(H+L) and peroxidase-conjugated streptavidin
were purchased from Jackson ImmunoResearch (West Grove, PA).
Flash-frozen human liver tissues were surgical remnant specimens
obtained from the Tissue Procurement Service of the Comprehensive
Cancer Center at the University of Alabama at Birmingham after
pathological diagnosis with UAB Institutional Review Board approval.
Liver tissues without pathological involvement were utilized for this
study.
2.1. Cell culture
Human HepG2 hepatocellular carcinoma cells were maintained in
Eagle's Minimum Essential Medium (MEM) containing 7% fetal bovine
serum, supplemented with non-essential amino acids and sodium
pyruvate. Human MMNK-1 cholangiocytes were maintained in
Dulbecco's Modiﬁed Eagle's Medium (DMEM) containing 7% fetal
bovine serum. Both cell lines were maintained in an atmosphere of 5%
CO2/95% air and passed at approximately 90% conﬂuency.
2.2. Expression of SULT1E1 and CFTR in HepG2 and MMNK-1 cells
CFTR and SULT1E1 levels were evaluated in HepG2 and MMNK-1
cells by immunoblot analysis. Cell lysates were prepared from
conﬂuent 60mmplates of HepG2 andMMNK-1 cells withmammalian
protein extraction reagent (M-PER, Pierce) as per manufacturer'sinstructions. Protein concentrations were estimated using the Brad-
ford assay with γ-globulin as the standard. Cell and tissue lysates
(120 μg protein) were resolved by 10% SDS-PAGE and electrotrans-
ferred to nitrocellulose membranes. Membranes were blocked with
5% bovine serum albumin then incubated with rabbit polyclonal anti-
SULT1E1 antibody (1/500) [8] or mouse monoclonal anti-CFTR
antibody (1/200) for 2 h. Goat anti-rabbit IgG horseradish peroxidase
(HRP) conjugate (1:60,000) or goat anti-mouse IgG HRP conjugate
(1:30,000), as appropriate, was used as the secondary antibody
followed by visualization of bound proteins with the SuperSignalWest
Pico System (Pierce).
2.3. Inhibition of CFTR expression in MMNK-1 cells by CFTR-siRNA
In order to inhibit CFTR expression in MMNK-1 cells using the
stable expression of siRNA, two complementary oligonucleotides were
synthesized targeting the CFTR sequence at nucleotides 225–243 (5′-
CCTGGAATTGTCAGACATA-3′), then annealed and ligated into the
pRNA-U6.1/Zeo expression vector. A control-siRNA vector was also
generated. MMNK-1 cells were transformed with either the pRNA-
U6.1/Zeo-CFTR-siRNA or pRNA-U6.1/Zeo-control-siRNA constructs
using Lipofectamine 2000 (Invitrogen). Transfected colonies were
isolated following zeocin selection (200 μg/ml) and expanded to
generate stably transformed MMNK-1 cells for experimental use.
To evaluate CFTR protein expression in MMNK-1 cells, cell lysates
were prepared from CFTR-siRNA MMNK-1 cells and control-siRNA
MMNK-1 cells with the M-PER reagent. Cell lysates (120 μg protein)
were resolved by SDS-PAGE and immunoblotted with the mouse
monoclonal anti-CFTR antibody. CFTR expression was also analyzed
in CFTR-siRNA MMNK-1 cells and control-siRNA MMNK-1 cells by
immunohistochemical analysis. MMNK-1 cells were plated on
coverslips and incubated for 24 h. Attached cells were ﬁxed in 70%
ethanol overnight, permeabilized and quenched with 3% H2O2. Cells
were then blocked with 3% goat serum and incubated with mouse
monoclonal anti-CFTR IgG (1:50) for 2 h. Samples were stained using
the BioGenex Liquid DAB Kit following the addition of biotin-SP-
conjugated afﬁniPure goat anti-mouse IgG(H+L) and peroxidase-
conjugated streptavidin, then counterstained, dehydrated and
mounted. Photographs were taken using a Nikon 20×40 imaging
system.
2.4. HepG2 and MMNK-1 cell co-culture
Co-culture experiments were performed with HepG2 cells and
either CFTR-siRNA or control-siRNA transfected MMNK-1 cells to
evaluate the effect of decreased CFTR levels on SULT1E1 expression in
HepG2 cells. Prior to co-culture, HepG2 cells were plated into 6-well
plates and allowed to attach overnight. MMNK-1 cells were placed
in 24 mm Transwell inserts and cultured separately. The Transwell
inserts possess a polycarbonate membrane with 0.4 μm pores
permitting separate co-culture of the two cell lines with free
exchange of media between the two cell types. The Transwell inserts
with CFTR- or control-siRNA transfected MMNK-1 cells were placed
into HepG2 culture wells and cultured for different time intervals.
After co-incubation, the Transwell inserts with the MMNK-1 cells
were removed and HepG2 cells were analyzed for SULT1E1
expression.
2.5. SULT1E1 expression analysis using quantitative RT-PCR
After HepG2 cells were co-cultured with stably CFTR-siRNA
transfected or control-MMNK-1 cells for different times, the cells
were separated and total RNA was extracted with STAT-60. Quanti-
tative RT-PCR was performed in an ABI 7500 thermal cycler using
TaqMan® Gene Expression Assays for human SULT1E1 and SULT1A1.
SULT1A1 is the major xenobiotic phenol SULT in human liver and was
Fig. 1.Differential expression of SULT1E1 and CFTR in HepG2 andMMNK-1 cells. Lysates
from HepG2 and MMNK-1 cells (120 μg protein) as well as from human liver (100 μg
protein) were prepared and resolved by SDS-PAGE then electrotransferred to
nitrocellulose membranes. The membrane-bound proteins were incubated with rabbit
polyclonal anti-SULT1E1 antibodies and mouse monoclonal anti-CFTR antibodies
(GeneTex). SULT1E1 immunoreactivity is shown in panel A and CFTR immunoreactivity
is shown in panel B.
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control for total RNA normalization. The PCR cycling protocol included
1 cycle each of 50 °C×2 min and 95 °C×10 min and then 40 cycles of
95 °C×15 s and 60 °C×1 min. Control HepG2 cells with no co-culture
were used as a calibrator sample. The amount of SULT1E1 and
SULT1A1 mRNA expression in these HepG2 cells was used for
comparison of expression in the co-cultured samples. Relative
expression was determined with the comparative method using the
ABI software.
2.6. Estradiol sulfation in co-cultured HepG2 cells
To evaluate E2 sulfation activity in HepG2 cells, cells were cultured
alone or co-cultured with CFTR-siRNA or control-siRNA MMNK-1 for
8 h. MMNK-1 cell-containing inserts were removed and the HepG2
cells incubated in fresh medium for 24 or 48 h. Lysate was then
prepared from the HepG2 cells with M-PER and assayed for E2
sulfation with our standard chloroform extraction method [8]. Brieﬂy,
lysate was incubated in Tris buffer, pH 7.4, with 20 nM [3H]-E2 and 3′-
phosphoadenosine 5′-phosphosulfate (the sulfonate donor) for
20 min, then the reaction was extracted with chloroform to remove
unsulfated E2. Radioactivity was determined in the aqueous phase to
quantify [3H]-E2 sulfate.
2.7. Alteration of estrogen-regulated gene expression in co-cultured
HepG2 cells
HepG2 cells were co-cultured with MMNK-1 cells by placing
Transwell inserts containing either control- or CFTR-siRNA MMNK-1
cells into HepG2 culture plates for 8 h. After removal of theMMNK-1 cell
inserts, HepG2 cellswere incubated for 48 h atwhich time total RNAwas
extracted using STAT-60. Carbonic anhydrase isoforms II and III (CA II, CA
III), glutathione-S-transferase-Pi (GST-Pi) and β-actin messages were
ampliﬁed via RT-PCR. The CA II primerswere: forward 5′-GGACAAGGTT-
CAGAGCATACTGTGG-3′; reverse 5′-ACATTCCAGAAGAGGAGGGTG-3′.
The CA III primers were: forward 5′-AATTGCCAAGGGGGAAAACC-3′;
reverse 5'-CATCAAGGAAAATCTGGAACTCGC-3′. The GST-Pi primers
were: forward 5′-AAGCCTTTTGAGACCCTGCTGTCC-3′; reverse 5′-
GTTTCCCGTTGCCATTGATG-3′. Speciﬁc PCR product formation was
analyzed in different cycles. Product formation was generally in the
linear range of synthesis in cycles 24–25. PCR products in the linear
synthesis range were resolved in 1% agarose gels and visualized with
ethidium bromide staining. Bands were quantiﬁed by scanning
densitometry.
2.8. Induction of IGF-1 expression in HepG2 cells after co-culture
The induction of IGF-1 message in HepG2 cells co-cultured with
CFTR- or control-MMNK-1 cells was investigated after co-culture for
8 h. TheMMNK-1 cells were removed and HepG2 cells were incubated
for 24 or 48 h in fresh medium. Total RNA was extracted and IGF-1
message was analyzed by qRT-PCR using Applied Biosystems primers
for human IGF-1. 18S rRNA was used as the endogenous control for
total RNA normalization.
2.9. Effect of MMNK-1 conditioned medium on HepG2 cell
SULT1E1 expression
To conﬁrm that a secreted paracrine factor is involved in the
induction of SULT1E1 in HepG2 cells after co-culture with Transwell-
separated MMNK-1 cells, medium from control-siRNA or CFTR-siRNA
cells was prepared and used as growth medium for HepG2 cells. Four
100 mm plates each of control-siRNA and CFTR-siRNA MMNK-1 cells
were prepared and allowed to achieve approximately 60% conﬂuency.
At this point, 20 ml of fresh mediumwas added for 48 h then removed
and applied to 60 mm plates of HepG2 cells at approximately 60%conﬂuency (5 ml/plate). Fifteen plates of HepG2 cells were prepared
with each the control- and CFTR-siRNA medium for triplicate
preparations of cell lysate with M-PER at times 0, 12, 24, 36 and
48 h. Lysate proteinwas determined by the Bradfordmethod, then the
E2 sulfation assay was performed for each lysate with equivalent
amounts of protein.
3. Results
3.1. Differential expression of SULT1E1 and CFTR in HepG2 hepatocytes
and MMNK-1 cholangiocytes
The expression of CFTR and SULT1E1 in MMNK-1 cells and HepG2
cells was analyzed. Fig. 1 shows the immunoblot analysis of CFTR and
SULT1E1 expression in HepG2 and MMNK-1 cells. SULT1E1 is readily
detectable in HepG2 cell lysate as well as in human liver lysate
whereas no SULT1E1 expression is detectable in MMNK-1 cell lysate
(Fig. 1A). In contrast, Fig. 1B demonstrates that CFTR protein is
detectable in liver lysate and in MMNK-1 cell lysate but not in HepG2
cell lysate, consistent with previous reports that CFTR is expressed in
cholangiocytes but not hepatocytes [15].
3.2. Inhibition of CFTR expression in CFTR-siRNA transfected
MMNK-1 cells
CFLD derives from a genetic dysfunction of CFTR expression or
structure resulting in the loss of activity [4]. Because human
cholangiocytes express signiﬁcant levels of CFTR [16], MMNK-1
cholangiocytes that natively express CFTR were used to establish a
cholangiocyte model to evaluate the loss of CFTR function. To repress
CFTR expression, MMNK-1 cells were stably transformed with the
pRNA-U6.1/Zeo-CFTR-siRNA plasmid. MMNK-1 cells for controls were
transformed with the pRNA-U6.1/Zeo-control-siRNA plasmid. Cell
lysates were prepared from both control and CFTR-siRNA MMNK-1
cells. Levels of CFTR were evaluated by immunoblot analysis in the cell
lysates using a mouse monoclonal anti-CFTR antibody. Fig. 2A shows
that CFTR protein levels in CFTR-siRNA transfectedMMNK-1 cells were
signiﬁcantly repressed in comparison with control-siRNA transfected
MMNK-1 cells. Relative quantiﬁcation demonstrated that CFTR
Fig. 2. Immunoblot analysis of CFTR in siRNA inhibited MMNK-1 cells. CFTR expression in MMNK-1 cells was repressed using the stable expression of speciﬁc siRNA as described in
Materials and methods. Lysates (120 μg protein) from control- and CFTR-siRNA transfected MMNK-1 cells were resolved by SDS-PAGE. CFTR levels were evaluated by immunoblot
analysis using mouse anti-CFTR monoclonal antibodies. Panel A, left, shows the immunoreactivity of the control-siRNA MMNK-1 lysate (left lane) and CFTR-siRNA MMNK-1 lysate
(right lane). Panel A, right, presents the results of the densitometric analysis of immunoblot results on the left. (B) Immunohistochemical analysis of CFTR levels in control-siRNA and
CFTR-siRNA MMNK-1 cells. MMNK-1 cells were plated on coverslips in 6-well plates and analyzed immunohistochemically for CFTR expression as described in Materials and
methods. Photographs were taken using a Nikon 20×40 imaging system. Panel B, left, shows the CFTR staining in control-siRNA MMNK-1 cells. Panel B, right, shows the staining in
CFTR-siRNA MMNK-1 cells.
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control cells.
Immunohistochemical analysis of intact control and CFTR-siRNA
MMNK-1 cells plated on glass cover slips carried out using a mouse
monoclonal anti-CFTR antibody veriﬁed the loss of CFTR expression
observed by immunoblot analysis. Control-siRNA transformed
MMNK-1 cells showed intense CFTR staining in the plasmaFig. 3. Time course of SULT1E1 and SULT1A1 expression in HepG2 cells during co-
culture with control- or CFTR-siRNA MMNK-1 cells. HepG2 cells were co-cultured with
either control-siRNA or CFTR-siRNA MMNK-1 cells for 30 min, 1 h, 2 h, 4 h, 8 h, 18 h or
24 h in triplicatewells. Total RNAwas then extracted and utilized for qRT-PCR analysis of
SULT1E1 or SULT1A1 as described in Materials and methods with ribosomal 18S RNA as
the endogenous control for total RNA normalization. mRNA expression levels were
calculated using the Ct method, where the calibrators were samples from normal
HepG2 cells with no MMNK-1 co-culture. Relative expression of SULT1E1 and SULT1A1
was expressed as fold-change between normal HepG2 cells and co-culturewith control-
or CFTR-siRNA MMNK-1 cells, using the mean value from 3 replicate wells. The results
are expressed as fold-change±s.d. and the standard deviations for the replicate wells
were no larger than 6%.membrane (Fig. 2B, left). In contrast, few CFTR-siRNA MMNK-1
cells were stained with the anti-CFTR IgG (Fig. 2B, right). Also, CFTR
staining was detected in only a few of the CFTR-siRNA MMNK-1 cells
indicating that the majority of the cells had CFTR levels below the
limit of detection.
3.3. SULT1E1 expression analysis using real-time quantitative RT-PCR
To determine whether the loss of CFTR expression in cholangio-
cytes alters the expression of SULT1E1 in HepG2 hepatocytes in a
paracrine mechanism, a membrane-separated Transwell co-cultureFig. 4. Selective induction of SULT1E1 activity in HepG2 cells co-cultured with CFTR-
siRNA MMNK-1 cells. HepG2 cells were cultured alone, or co-cultured with control-
siRNA or CFTR-siRNA-MMNK-1 cells for 8 h then transferred to fresh medium and
incubated for 24 or 48 h alone. Cellular lysate was then prepared with M-PER and
assayed for E2 sulfation activity as described in Materials and methods. E2 sulfation
activity is expressed as pmol/min/mg protein. Each point represents the mean of
SULT1E1 activity in lysate prepared from three separate wells and each lysate was
assayed in triplicate. SULT1E1 activity is expressed as pmol E2 sulfated per min per mg
protein±s.d. The asterisk denotes a signiﬁcant difference at pb0.01 from the SULT1E1
sulfation rate in HepG2 cells with no co-culture using the Student's T-test.
Fig. 6. SULT1E1 activity in HepG2 cells after co-culture in MMNK-1 cell conditioned
medium. Lysatewas prepared fromHepG2 cellsmaintained in conditionedmedium from
control- or CFTR-siRNAMMNK-1 cells for 0, 12, 24, 36 or 48 h, then assayed for 20 nM E2
sulfation activity. Results are expressed as pmol E2 sulfated/min/mg protein±s.d., and
represent themeans of triplicate SULT1E1 assays in each lysate from triplicate wells. The
asterisk represents a signiﬁcant difference fromHepG2 cellsmaintained in control-siRNA
MMNK-1 conditioned medium, at pb0.01 with the Student's T-test.
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Transwell inserts were co-cultured with HepG2 cells for different
time intervals prior to the isolation of HepG2 cell RNA for the
analysis of SULT1E1 and SULT1A1 message by qRT-PCR. As shown in
Fig. 3, SULT1E1 message was signiﬁcantly up-regulated in a time-
dependent manner in HepG2 cells co-cultured with CFTR-repressed
MMNK-1 cells for 4 h or longer. In contrast, SULT1A1 message, a
major SULT isoform in human liver [16] was not altered under these
same conditions indicating that this induction is speciﬁc to SULT1E1.
SULT2A1 and cytochrome P450 3A4 message expression were also
not induced by co-culture with the CFTR-siRNA MMNK-1 cells (data
not shown). No signiﬁcant increase in the expression of either
SULT1E1 or SULT1A1 was detected in HepG2 cells co-cultured with
control-siRNA MMNK-1 cells or with normal, untransformed
MMNK-1 cells.
3.4. SULT1E1 activity in co-cultured HepG2 cells
To evaluate the effect of HepG2 cell co-culture with CFTR-siRNA
MMNK-1 cells on SULT1E1 activity, HepG2 cells were cultured alone
or co-cultured for 8 h with CFTR-siRNA or control-siRNA cells then
maintained in fresh medium for 24 h or 48 h after removal of
Transwell inserts. Fig. 4 shows that lysates prepared from HepG2
cells cultured alone or with control-siRNA MMNK-1 cells for 24 h or
48 h demonstrate similar rates of E2 sulfation. In contrast, HepG2
cells co-cultured with CFTR-siRNA MMNK-1 cells show signiﬁcantly
elevated E2 sulfation activity at both 24 and 48 h after removal of
Transwell inserts compared to control-siRNA HepG2 cells. Further-
more, greater E2 sulfation activity was observed in these HepG2 cells
24 h after separation from the CFTR-siRNA MMNK-1 cells at 48 h
after separation. The decrease in SULT1E1 activity in these HepG2
cells 48 h after removal from co-culture suggests that co-culture of
the HepG2 and MMNK-1 cells is required for continued induction of
SULT1E1 expression.Fig. 5. Effect of co-culture with CFTR-siRNA-MMNK-1 cells on estrogen-regulated gene
expression in HepG2 cells. HepG2 cells were co-cultured with control- or CFTR-siRNA-
MMNK-1 cells for 8 h. MMNK-1 cells were removed and HepG2 cells were incubated in
fresh medium for 48 h. Total RNAwas prepared and utilized for RT-PCR ampliﬁcation of
CA II, CA III, GST-Pi and β-actin messages. PCR reactions from the linear phase of the
ampliﬁcation cycle (24–25 cycles) were resolved in 1% agarose gels, visualized with
ethidium bromide staining and quantiﬁed by scanning densitometry. IGF-1 message
was analyzed by qRT-PCR as described in Materials and methods. IGF-1 mRNA
expression levels were calculated using the Ct method, where the calibrators were the
samples from normal HepG2 cells without co-culture with MMNK-1. Relative IGF-1
message levels are expressed as percent change between co-culture with CFTR-siRNA or
control-siRNA MMNK-1 cells and control HepG2 cells that were not co-cultured. Each
point represents themean±s.d. of four reactions and the asterisk denotes signiﬁcance at
pb0.01 as compared to message levels in control cells using the Student's T-test.3.5. Alteration of estrogen-regulated gene expression in co-cultured
HepG2 cells
CFTR(−/−) mice demonstrate altered expression of several E2-
regulated proteins in liver that correlate with the levels of SULT1E1
activity [7]. To investigate whether co-culture of HepG2 cells with
CFTR-siRNA MMNK-1 cells resulted in changes in expression of E2-
regulated proteins, control- or CFTR-siRNA MMNK-1 cells were co-
cultured with HepG2 cells for 8 h. MMNK-1 cells were then removed
and HepG2 cells were incubated for an additional 48 h prior to the
isolation of total RNA. CA II, CA III, GST-Pi, IGF-1 and β-actin
messages were ampliﬁed via RT-PCR with the appropriate primers.
PCR products from the linear range of the ampliﬁcation curves were
resolved by agarose gel electrophoresis and visualized by staining
with ethidium bromide. Fig. 5 shows that CA II, GST-Pi and IGF-1
messages in HepG2 cells were decreased in the cells co-cultured
with CFTR-siRNA MMNK-1 cells in comparison to HepG2 cells co-
cultured with control-siRNA MMNK-1 cells. There was no apparent
difference in CA III and β-actin message levels between these same
cells. Both CA and GST-Pi also demonstrated decreased expression in
the livers of the CFTR(−/−) mice [7]. Additionally, hepatic IGF-1
message levels were decreased in the CFTR(−/−) mice and were
inversely correlated with SULT1E1 activity.
3.6. Effect of MMNK-1 conditioned medium on HepG2 cell
SULT1E1 expression
To support our hypothesis that CFTR-siRNA MMNK-1 cells
secrete a paracrine factor that affects SULT1E1 in HepG2 cells,
SULT1E1 activity was evaluated in lysate prepared from HepG2 cells
grown in conditioned medium from either control-siRNA or CFTR-
siRNA MMNK-1 cells. As shown in Fig. 6, SULT1E1 activity is
signiﬁcantly elevated in SULT1E1 cells maintained in CFTR-siRNA
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most signiﬁcant elevation at 36 h of culture. By 48 h of culture,
SULT1E1 activity begins to decline, suggesting that the paracrine
factor secreted by the CFTR-siRNA MMNK-1 cells is either depleted
or labile, and may require continuous production to maintain
elevated SULT1E1 levels.
4. Discussion
SULT1E1 in both mice and humans is responsible for the sulfation
and inactivation of E2 at physiological concentrations [16,17]. Human
SULT1E1 has a Km for E2 of 4 nM and is capable of inhibiting the
activation of estrogen receptor-α by physiological concentrations of
E2 in human endometrial cells [18]. Therefore, signiﬁcant changes in
SULT1E1 activity would be expected to decrease the levels of free
active E2 in hepatocytes and as a consequence alter estrogen-
regulated processes. Our laboratory has previously reported that
most CFTR-ΔF508 and CFTR(−/−) mice exhibit increased levels of
liver SULT1E1 activity [6,7]. SULT1E1 activity in livers of CFTR(−/−)
mice is generally 20–30-fold greater than the levels in CFTR wild
type or (+/−) littermates [6]. The increases in SULT1E1 expression in
CFTR (−/−) mouse liver correlate with changes in E2-regulated
proteins such as GST-Pi, CYP2B9 and CA II [7]. These proteins have
signiﬁcant roles in altering the effects of oxidative stress, the
metabolism of toxic xenobiotics and the generation of reactive
oxygen species [19].
CF liver pathology is associated with the functional loss of CFTR in
cholangiocytes, the intrahepatic biliary epithelial cells [4]. CFTR is
not expressed in the more abundant hepatocytes [12] nor was CFTR
expression detected in HepG2 cells (Fig. 1). In contrast, SULT1E1 is
expressed in hepatocytes and is not detectable in MMNK-1
cholangiocytes (Fig. 1) [7]. Loss of CFTR function in cholangiocytes
has several physiological consequences in the liver. There are
changes in the composition and viscosity of bile limiting its role in
lipid absorption [15]. There are alterations in the composition and
interhepatic circulation of bile acids [20]. In addition, overt LD is a
relatively frequent and early complication of CF occurring in
approximately 20% of patients [20]. The initiating event is unknown
although it appears to involve steatosis and a progressive ﬁbrogenic
process leading to cirrhosis and portal hypertension [4,21]. Altera-
tions in liver function associated with the loss of CFTR activity may
be responsible for part of the variability in the clinical manifestations
of CFLD.
In liver, CF is characterized by the loss of CFTR function in
cholangiocytes. In the CFTR(−/−) mouse models the loss of CFTR in
cholangiocytes is associated with an induction of SULT1E1 activity in
hepatocytes. Whether an induction of SULT1E1 occurs in human CF
liver is not known. The investigation of SULT1E1 expression in CFLD
is signiﬁcantly limited by the severe lack of availability of human CF
liver tissue. Therefore, to establish that the repression of CFTR
function in human cholangiocytes was capable of eliciting the
induction of SULT1E1 in adjacent hepatocytes, a membrane-
separated co-culture system was used. The hypothesis was that the
loss of CFTR activity in cholangiocytes results in release of a factor
that acts via a paracrine mechanism to induce SULT1E1 expression in
hepatocytes. CFTR expression in MMNK-1 cholangiocytes was stably
repressed using siRNA then the MMNK-1 cells were co-cultured with
HepG2 cells in a Transwell system wherein the cells were separated
by a 0.4 μm semi-permeable membrane. CFTR-repressed MMNK-1
cells selectively induced the expression of SULT1E1 in the co-
cultured HepG2 cells. The induction of SULT1E1 indicates that
increased SULT1E1 expression in the livers of CF patients is possible.
These characteristics are indicative of transcriptional regulation of
SULT1E1. Also, as observed in the CFTR(−/−) mice and HepG2 cells
stably expressing SULT1E1 [7], the expression of IGF-1, CA II and GST-
Pi were altered in the HepG2 cells co-cultured with CFTR-siRNAMMNK-1 cells. In CFTR(−/−) mice CA III expression in the liver was
down-regulated whereas the expression of CA II which is localized
exclusively in cholangiocytes [22] was not analyzed. In human liver,
both the CA II and CA III isoforms are expressed in hepatocytes [23]
and only the expression of CA II was decreased in the presence of
increased SULT1E1 activity (Fig. 5).
The co-culture model provides evidence for the paracrine regula-
tion of hepatocytes by CF cholangiocytes. The underlying mechanism
for the induction of SULT1E1 expression in the HepG2 cells by CFTR-
deﬁcient MMNK-1 cells is unknown although several mechanisms are
possible. Dysfuntional CFTR potentiates cholangiocyte involvement in
inﬂammatory reactions [4] that could activate inﬂammatory factors in
co-cultured hepatocytes and thus promote transcription of SULT1E1.
Disruption of CFTR in cholangiocytes may result in abnormal cAMP-
stimulated Cl−, K+ and HCO3− secretion [24]. Secondmessage systems in
co-cultured hepatocytes may be affected by an imbalance in ion and
water across the cell membrane with a consequent stimulation of
transcription. The disruptions in bile acid synthesis and metabolism
could result in the production and efﬂux of sterol compounds capable
of activating orphan nuclear receptors in hepatocytes. Activation of
the liver x receptor (LXR) has been reported to regulate SULT1E1
expression in mice [25].
Consistent with the ﬁndings in CFTR-KO mice, IGF-1 expression is
decreased in the HepG2 cells with SULT1E1 activity induced by co-
culture with CFTR-siRNA MMNK-1 cells (Fig. 5). Our previous results
suggest that increased SULT1E1 activity in mouse liver and HepG2
hepatocytes results in a reduction of IGF-1 message expression. In
HepG2 cells, E2 increases STAT5b activation following stimulation by
growth hormone. Increased SULT1E1 activity in HepG2 cells is
associated with a decrease in both STAT5b activation and IGF-1
message levels. IGF-1 has been reported to have protective effects on
cholangiocyte survival during primary biliary cirrhosis [26] and to
interact with E2 to stimulate cholangiocyte proliferation in a growth
hormone stimulated process [27,28]. An increase in SULT1E1 activity
in hepatocytes may then be associated with reduced IGF-1 synthesis
resulting in greater intrahepatic cholangiocyte damage and biliary
dysfunction. Moreover, estrogens may target the biliary tree, where
they modulate proliferative and secretory activities in cholangiocytes
[24]. Estrogens have an important function in growth and cytokine
signaling by modulating the proliferative response of cholangiocytes
to damage via estrogen receptor activation [28]. Thus, in addition to its
effects in the hepatocytes, increased hepatic SULT1E1 activity may
result in alteration of cholangiocyte activity by decreasing liver
estrogen levels.
Results found with the MMNK-1/HepG2 co-culture model
indicate that the loss of CFTR function in cholangiocytes has the
capability of eliciting paracrine effects on hepatocytes. Paracrine
regulation of SULT1E1 activity generates a mechanism for altering
many E2-regulated processes in liver. In addition, the induction of
SULT1E1 activity and disruption in E2-regulated protein expression
may have subtle or obvious effects on hepatocyte metabolism and
function. The sensitivity of SULT1E1 to paracrine induction may be a
factor in the variable appearance of LD or liver problems in CF
patients. The role for increased E2 sulfation in the development of LD
requires further examination. The paracrine mechanism for the
induction of SULT1E1 has not been established and it is not known
whether SULT1E1 expression is induced in other human tissues
including breast, endometrium, testis or gastrointestinal tract.
However, the results indicate that the loss of CFTR activity in a
tissue may have important speciﬁc paracrine regulatory effects in
different and distant tissues.
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